English | 繁體

Search in the results

UM

Browse/Search Results:  1-5 of 5 Help

Selected(0)Clear Items/Page:    Sort:
Extracellular Vesicles Maintain Blood-Brain Barrier Integrity by the Suppression of Caveolin-1/CD147/VEGFR2/MMP Pathway After Ischemic Stroke Journal article
Yiyang Li, Jiali Chen, Xingping Quan, Ying Chen, Yan Han, Jinfen Chen, Li Yang, Youhua Xu, Xu Shen, Ruibing Wang, Yonghua Zhao. Extracellular Vesicles Maintain Blood-Brain Barrier Integrity by the Suppression of Caveolin-1/CD147/VEGFR2/MMP Pathway After Ischemic Stroke[J]. International Journal of Nanomedicine, 2024, 19, 1451-1467.
Authors:  Yiyang Li;  Jiali Chen;  Xingping Quan;  Ying Chen;  Yan Han; et al.
Favorite | TC[WOS]:3 TC[Scopus]:2  IF:6.6/7.5 | Submit date：2024/04/03
Cd147  Caveolin-1  Vegfr2  Blood-brain Barrier  Extracellular Vesicles  Ischemic Stroke  Matrix Metalloproteinase  
Upregulated expression of MMP family genes is associated with poor survival in patients with esophageal squamous cell carcinoma via regulation of proliferation and epithelial-mesenchymal transition Journal article
Xu, Guifeng, Ou, Ling, Liu, Ying, Wang, Xiao, Liu, Kaisheng, Li, Jieling, Li, Junjun, Wang, Shaoqi, Huang, Dane, Zheng, Kai, Wang, Shaoxiang. Upregulated expression of MMP family genes is associated with poor survival in patients with esophageal squamous cell carcinoma via regulation of proliferation and epithelial-mesenchymal transition[J]. Oncology Reports, 2020, 44(1), 29-42.
Authors:  Xu, Guifeng;  Ou, Ling;  Liu, Ying;  Wang, Xiao;  Liu, Kaisheng; et al.
Favorite | TC[WOS]:4 TC[Scopus]:7  IF:3.8/3.4 | Submit date：2021/12/06
Epithelial-mesenchymal Transition  Esophageal Squamous Cell Carcinoma  Gene Expression Omnibus  Matrix Metalloproteinase Family  Prognostic Value  The Cancer Genome Atlas  
Surface Modifier Effects on Gold Nanoprobe for the Assay of Matrix Metalloproteinases Journal article
Hong,Jin, Chen,Yu Feng, Ma,Yu, Zhang,Fen Fen, Wang,Chun Ming, Ding,Ya. Surface Modifier Effects on Gold Nanoprobe for the Assay of Matrix Metalloproteinases[J]. Advanced Biosystems, 2018, 2(10).
Authors:  Hong,Jin;  Chen,Yu Feng;  Ma,Yu;  Zhang,Fen Fen;  Wang,Chun Ming; et al.
Favorite | TC[WOS]:7 TC[Scopus]:5  IF:4.100/4.000 | Submit date：2021/03/02
Bovine Serum Albumin  Gold Nanoprobe  Matrix Metalloproteinase Assay  Polyethylene Glycol  Surface Modifier  
Simvastatin protects diabetic rats against kidney injury through the suppression of renal matrix metalloproteinase-9 expression Journal article
Yao X.-M., Ye S.-D., Zai Z., Chen Y., Li X.-C., Yang G.-W., Wang Y.-X., Chen K.. Simvastatin protects diabetic rats against kidney injury through the suppression of renal matrix metalloproteinase-9 expression[J]. Journal of Endocrinological Investigation, 2010, 33(5), 292-296.
Authors:  Yao X.-M.;  Ye S.-D.;  Zai Z.;  Chen Y.;  Li X.-C.; et al.
Favorite | TC[WOS]:23 TC[Scopus]:27 | Submit date：2019/01/16
Diabetes Mellitus  Diabetic Nephropathy  Matrix Metalloproteinase-9  Simvastatin  
Rosiglitazone protects diabetic rats against kidney injury through the suppression of renal matrix metalloproteinase-9 expression Journal article
Yao X.-M., Ye S.-D., Chen Y., Zai Z.-M., Li X.-C., Wang Y.-X., Chen K.. Rosiglitazone protects diabetic rats against kidney injury through the suppression of renal matrix metalloproteinase-9 expression[J]. Diabetes, Obesity and Metabolism, 2009, 11(5), 519-522.
Authors:  Yao X.-M.;  Ye S.-D.;  Chen Y.;  Zai Z.-M.;  Li X.-C.; et al.
Favorite | TC[WOS]:11 TC[Scopus]:11 | Submit date：2019/01/16
Diabetes Mellitus  Diabetic Nephropathy  Matrix Metalloproteinase-9  Rosiglitazone